EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Journal of Cystic Fibrosis

ISSN 1569-1993 · Elsevier BV

Neueste Artikel

  1. Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension study

    Jennifer L. Goralski, Cori Daines, Jessica E. Pittman, Jonathan H. Rayment, Philip Robinson, Rebecca Thursfield, Florian Stehling, Felix Ratjen, Neil Ahluwalia, Peng Shi, Mengdi Lu, Tanya G. Weinstock, Marcus A. Mall, Ronald Gibson, Jennifer Goralski, Daniel Weiner, Carlos Milla, Jessica Pittman, Anne Stone, Alvin Singh, James Chmiel, Gregory Sawicki, Jordana Hoppe, Brooke Moore, Cori Daines, Felix Ratjen, Jonathan Rayment, Susanna McColley, Marcus Mall, Florian Stehling, Jane Davies, Rebecca Thursfield, Philip Robinson, Claire Wainwright, Barry Clements

    Erschienen: 2026-09DOI: 10.1016/j.jcf.2026.05.014

  2. Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR

    Tamarah Katz, Josie van Dorst, Bernadette Prentice, Christine L. Chan, Dimitri Declercq, Tanja Gonska, Jodi Grunert, Daina Kalnins, Christina N. Katsagoni, Amanda Leonard, Catherine M. McDonald, Paul McNally, Monika Mielus, Anne Munck, Lutz Naehrlich, Elizabeth Owen, Chris Smith, Sarah Jane Schwarzenberg, Vito Terlizzi, Michael Wilschanski, Chee Y. Ooi

    Erschienen: 2026-07DOI: 10.1016/j.jcf.2026.02.004

  3. Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population

    Julie Semenchuk, Yumi Naito, Susan C. Charman, Siobhán B Carr, Jamie Duckers, Stephanie Y. Cheng, Bruce C. Marshall, Albert Faro, Alexander Elbert, Christopher H. Goss, Pierre-Régis Burgel, Carla Colombo, Marco Salvatore, Nataliya Kashirskaya, Laura Kirwan, Peter G Middleton, Lutz Naehrlich, Maria Dolores Pastor-Vivero, Andreas Jung, Egil Bakkeheim, Anna Zolin, Annalisa Orenti, Domenique D. Zomer-van Ommen, Marco Zampoli, Anne L. Stephenson, Susannah Ahern, Rasa Ruseckaite, Sabine Burghart, Andrea Lakatos-Krepcik, Johannes Eder, Peter Jaksch, Katharina Kainz, Margit Kallinger, Alexander Leitner, Marta Mozdzen, Andreas Pfleger, Sabine Renner, Nicole Strasser, Martin Stadlinger, Christina Thir

    Erschienen: 2026-07DOI: 10.1016/j.jcf.2026.02.009

  4. Impact of Elexacaftor-Tezacaftor-Ivacaftor on fungal colonisation in children and adolescents with cystic fibrosis

    Emilie Sitterlé, Anne-Sophie Bonnel, Tiphaine Roussey-Bihouee, Aurore Blondé, Mélanie Ribault, Nathalie Wizla, Claire Bresson, Florence Persat, Danielle Maubon, Jordan Leroy, Fathia Hassani, Lilia Benhala, Morgane Mounier, Sadri Znaidi, Agnès Ferroni, Marie-Elisabeth Bougnoux, Isabelle Sermet-Gaudelus, Baptiste Arnouat, Melissande Baravalle, Mahassen Barboura, Audrey Barzic, Lilia Benhalla, Myriam Benhamida, Katia Bessaci, Antoine Bessou, Tiphaine Bihouée, Aurore Blonde, Anne-Sophie Bonnel, Nesrine Bouleghlem, Stéphanie Bui, Frédérique Chedevergne, Camille Cisterne, Harriet Corvol, Laure Cosson, Laure Couderc, Carole Couette, Marie-Laure Dalphin, Paola de Carli, Eric Deneuville, Raphael Enaud

    Erschienen: 2026-07DOI: 10.1016/j.jcf.2026.02.012

  5. The impact of progressive expansion of elexacaftor-tezacaftor-ivacaftor availability on lung transplant for cystic fibrosis in France

    Théo Dhôte, Dominique Grenet, Martine Reynaud-Gaubert, Eva Chatron, Benjamin Renaud-Picard, Adrien Tissot, Julie Macey, Marlène Murris-Espin, Vincent Bunel, Isabelle Sermet-Gaudelus, Nicolas Carlier, Véronique Boussaud, Reem Kanaan, Camille Legeai, Richard Dorent, Sandra de Miranda, Jennifer Da Silva, Pierre-Régis Burgel

    Erschienen: 2026-07DOI: 10.1016/j.jcf.2026.03.003

  6. Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey

    Andrea Gramegna, Carlo Magnoni, Chiara Premuda, Gianfranco Alicandro, Onno Akkerman, Adelina Amorim, Pilar Azevedo, Stephen Bourke, Vincenzo Carnovale, Filia Diamantea, Libor Fila, Freddy Frost, Rosa Maria Giron Moreno, Camelia Pescaru, Eva Polverino, Almudena Felipe Montiel, Marta Rachel, Gergana Petrova Stoyanova, Eva Van Braeckel, Sonia Volpi, Andrea Vukić -Dugac, Sabine Wege, Nicholas J. Simmonds, Barry J. Plant, Damian G. Downey, Silke van Koningsbruggen-Rietschel, Pierre-Régis Burgel, Francesco Blasi

    Erschienen: 2026-07DOI: 10.1016/j.jcf.2026.03.005

  7. Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis

    Eva Van Braeckel, Andrew T. Braun, Nicholas J. Simmonds, Peter J. Barry, Jane C. Davies, Marie E. Egan, Allen Lapey, Marcus A. Mall, Edward F. McKone, Daniel Peckham, Marijke Proesmans, Bonnie Ramsey, Saioa Vicente Santamaria, Daniel Smith, Jennifer L. Taylor-Cousar, Elizabeth Tullis, Elke De Wachter, Nick Withers, Neil Ahluwalia, Sarah Conner, Mark Jennings, Yiyue Lou, Tanya G. Weinstock, Dominic Keating

    Erschienen: 2026-07DOI: 10.1016/j.jcf.2026.03.016

Jahrgänge

2026 · 9442025 · 1.7162024 · 1.7362023 · 1.5572022 · 1.3492021 · 1.2762020 · 7752019 · 8412018 · 6162017 · 7662016 · 6182015 · 6492014 · 5792013 · 6422012 · 6232011 · 4912010 · 5472009 · 5032008 · 6752007 · 4452006 · 4832005 · 5352004 · 1032003 · 542002 · 50

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.